Teriparatide (PTH 1-34) studies: 484 papers with results
Page 10 of 10
- Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.
Gomberg SJ · The Journal of clinical endocrinology and metabolism · 2011
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
Sugimoto T · Current medical research and opinion · 2013
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial.
Morita A · Journal of orthopaedic surgery and research · 2020
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levels.
Takada J · Journal of bone and mineral metabolism · 2021
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- A pilot study comparing daily teriparatide with monthly cycles of teriparatide and raloxifene.
Goel H · Archives of osteoporosis · 2021
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.
Hald JD · JAMA · 2026
Not a test of Teriparatide (PTH 1-34) alone · 5 results
- Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Burshell AL · Bone · 2010
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients.
Ebina K · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance.
Foster SA · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Ramchand SK · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate.
Tsai JN · The Journal of clinical endocrinology and metabolism · 2015
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05.
Hosoi T · Journal of bone and mineral metabolism · 2025
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Achieving osteoporosis treat-to-target goals with teriparatide or alendronate: sub-analysis of Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
Hagino H · Journal of bone and mineral metabolism · 2024
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).
Leder BZ · Bone · 2017
Not a test of Teriparatide (PTH 1-34) alone · 3 results
- Combined teriparatide and denosumab therapy accelerates spinal fusion following posterior lumbar interbody fusion.
Ide M · Orthopaedics & traumatology, surgery & research : OTSR · 2018
Not a test of Teriparatide (PTH 1-34) alone · 3 results
- Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture.
Hiligsmann M · Seminars in arthritis and rheumatism · 2019
Not a test of Teriparatide (PTH 1-34) alone · 7 results
- Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
Huang HT · Menopause (New York, N.Y.) · 2012
Not a test of Teriparatide (PTH 1-34) alone · 3 results
- Variability in the measured response of bone to teriparatide.
Heaney RP · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
Not a test of Teriparatide (PTH 1-34) alone · 3 results
- Adherence and persistence of daily and twice-weekly teriparatide treatment in postmenopausal women with high-risk of fracture.
Mochizuki T · Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry · 2026
Not a test of Teriparatide (PTH 1-34) alone · 3 results
- Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures.
Gallagher JC · The Journal of clinical endocrinology and metabolism · 2005
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience.
Briot K · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2009
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.
Le QA · The Annals of pharmacotherapy · 2019
Not a test of Teriparatide (PTH 1-34) alone · 8 results
- Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction.
Mansoori MN · Bone · 2017
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide.
Holm J · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2014
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
Mori S · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Treatment of Osteoporosis With Anabolic Agents and the Risk of Primary Bone Cancers: A Study of 44,728 Patients Treated With Teriparatide and Abaloparatide.
McDonald CL · The Journal of the American Academy of Orthopaedic Surgeons · 2023
Not a test of Teriparatide (PTH 1-34) alone · 4 results
- Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
Takeuchi Y · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
Not a test of Teriparatide (PTH 1-34) alone · 2 results
- Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide.
Cosman F · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
Not a test of Teriparatide (PTH 1-34) alone · 6 results
- The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.
Andrews EB · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2012
Not a test of Teriparatide (PTH 1-34) alone · 1 result
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
Geusens P · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
Not a test of Teriparatide (PTH 1-34) alone · 1 result
- Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.
Muschitz C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
Not a test of Teriparatide (PTH 1-34) alone · 1 result
- Effect exerted by Teriparatide upon Repair Function of β-tricalcium phosphate to ovariectomised rat's femoral metaphysis defect caused by osteoporosis.
Tao ZS · Injury · 2015
Not a test of Teriparatide (PTH 1-34) alone · 1 result
- Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures.
Fukuda F · Biologics in therapy · 2014
Not a test of Teriparatide (PTH 1-34) alone · 1 result
- Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Kendler DL · Bone · 2020
Not a test of Teriparatide (PTH 1-34) alone · 1 result